Postmenopausal insomnia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Female aged 45–65 years right-handed; (2) Meeting the diagnostic criteria for the late postmenopausal stage per STRAW+10 and for chronic insomnia per ICSD-3; (3) Pittsburgh Sleep Quality Index (PSQI) score >7; (4) No medication use for at least 2 weeks prior to study entry; (5) Voluntary participation in the study with signed informed consent.
Exclusion criteria
Exclusion criteria: 1) Bilateral oophorectomy ovarian organic diseases premature ovarian failure polycystic ovary syndrome and hypothalamic amenorrhea patients;2) Patients with systemic diseases such as hypertension diabetes coronary heart disease and obesity (BMI = 28);3) Patients with severe life-threatening primary diseases such as cardiovascular hepatic renal and hematologic disorders;4) Patients with impaired consciousness who cannot express subjective discomfort symptoms;5) Personal or first-degree relatives with a history of psychiatric disorders or organic neurological diseases;6) Patients with insomnia caused by alcohol abuse and/or substance abuse (including sleeping pills);7) Patients with severe depression or anxiety symptoms;8) Patients with severe headaches migraines a history of head trauma or previous surgeries;9) Patients who have received estrogen serotonin reuptake inhibitors or other alternative therapies within 4 weeks before enrollment;10) History of anticoagulant use or routine use of sedatives or anxiolytics;11) Pregnancy planned pregnancy or breastfeeding;12) Patients with claustrophobia implanted metallic devices metal braces or other contraindications for MRI scanning.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| insomnia assessment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical evaluation of postmenopausal relevance;Neuropsychological test;Neuroimaging test;Blood test;gut test; | — |
Countries
China
Contacts
Sichuan Jinxin Xinnan Women and Children's Hospital(Bisheng Branch)